IMO the FDA has been in the process of reviewing the current trial data. asking questions on the data and getting answers from IONIS & BIOGEN. The changing of the trial endpoints and stopping trial enrollment is significant and would not have occurred without a lot of analysis by the FDA. We are in clean -up mode with the FDA to stopping the trial and proceeding to filing NDA.
By the way these stupid shorts are going to have to cover under some serious upward movement in the stock price "Good luck To them"